1. Home
  2. SEER vs IAE Comparison

SEER vs IAE Comparison

Compare SEER & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$2.09

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

IAE

Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.62

Market Cap

97.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
IAE
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
97.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
SEER
IAE
Price
$2.09
$8.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
77.2K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
10.21%
EPS Growth
9.40
N/A
EPS
N/A
N/A
Revenue
$16,578,000.00
N/A
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.55
$6.65
52 Week High
$2.41
$9.27

Technical Indicators

Market Signals
Indicator
SEER
IAE
Relative Strength Index (RSI) 59.16 44.73
Support Level $1.70 $8.43
Resistance Level $2.09 $9.25
Average True Range (ATR) 0.07 0.21
MACD 0.01 -0.04
Stochastic Oscillator 67.73 22.08

Price Performance

Historical Comparison
SEER
IAE

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.

Share on Social Networks: